Market Value331,044,132
Total Holdings54
File Date2024-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ABSI / Absci Corporation
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
KRYS / Krystal Biotech, Inc.
INSM / Insmed Incorporated Call
CATX / Perspective Therapeutics, Inc.
RZLT / Rezolute, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
PMVP / PMV Pharmaceuticals, Inc.
PTCT / PTC Therapeutics, Inc.
CYTK / Cytokinetics, Incorporated
CABA / Cabaletta Bio, Inc.
ANTX / AN2 Therapeutics, Inc.
BIOHAVEN LTD / CALL (G1110E907)
MLTX / MoonLake Immunotherapeutics
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
NUVB / Nuvation Bio Inc.
SVRA / Savara Inc.
ARVN / Arvinas, Inc.
INSM / Insmed Incorporated
OLMA / Olema Pharmaceuticals, Inc.
ATYR / aTyr Pharma, Inc.
EWTX / Edgewise Therapeutics, Inc.
CGON / CG Oncology, Inc.
BPMC / Blueprint Medicines Corporation
TNYA / Tenaya Therapeutics, Inc.
NGNE / Neurogene Inc.
TSHA / Taysha Gene Therapies, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.
PCVX / Vaxcyte, Inc.
HLXB / Helix Acquisition Corp. II
KRRO / Korro Bio, Inc.
TGTX / TG Therapeutics, Inc.
IMVT / Immunovant, Inc.
JANX / Janux Therapeutics, Inc.
ENGN / enGene Holdings Inc.
ROIV / Roivant Sciences Ltd.
SNDX / Syndax Pharmaceuticals, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
RGNX / REGENXBIO Inc.
VRDN / Viridian Therapeutics, Inc.
REPL / Replimune Group, Inc.
AXSM / Axsome Therapeutics, Inc.
SRPT / Sarepta Therapeutics, Inc.
SYRE / Spyre Therapeutics, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
BBIO / BridgeBio Pharma, Inc.
PRQR / ProQR Therapeutics N.V.
VKTX / Viking Therapeutics, Inc.
LRMR / Larimar Therapeutics, Inc.
SLNO / Soleno Therapeutics, Inc.
ANNX / Annexon, Inc. Call
ANNX / Annexon, Inc.
ALNY / Alnylam Pharmaceuticals, Inc. Put
ELEV / Elevation Oncology, Inc.
RVNC / Revance Therapeutics, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
NTLA / Intellia Therapeutics, Inc.
CTMX / CytomX Therapeutics, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
ITCI / Intra-Cellular Therapies, Inc.
WVE / Wave Life Sciences Ltd.
BHVN / Biohaven Ltd.
MGNX / MacroGenics, Inc.
RAPT / RAPT Therapeutics, Inc. Call
CAPR / Capricor Therapeutics, Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc.
SGMT / Sagimet Biosciences Inc.
CRBP / Corbus Pharmaceuticals Holdings, Inc. Put
SMMT / Summit Therapeutics Inc.
CRVS / Corvus Pharmaceuticals, Inc.
DYN / Dyne Therapeutics, Inc.